(Q44051171)

29 November 2017

Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients (English)

1 reference

29 November 2017

1 reference

1 reference

A Asberg

1

1 reference

29 November 2017

A Hartmann

2

1 reference

29 November 2017

E Fjeldså

3

1 reference

29 November 2017

S Bergan

4

1 reference

29 November 2017

H Holdaas

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

American Journal of Transplantation

29 November 2017

1 reference

29 November 2017

1

1 reference

29 November 2017

4

1 reference

29 November 2017

382-386

1 reference

Long-term survival in renal transplant recipients with graft function

29 November 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

7 January 2021

Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

7 January 2021

Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

7 January 2021

Efficacy and pharmacokinetics of simvastatin in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

7 January 2021

Atorvastatin: a hydroxymethylglutaryl-coenzyme A reductase inhibitor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

7 January 2021

Post-transplant hyperlipidaemia: low-dose lovastatin lowers atherogenic lipids without plasma accumulation of lovastatin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

7 January 2021

Interaction between lovastatin and cyclosporine A after heart and kidney transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

7 January 2021

Plasma concentration profiles of simvastatin 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without ciclosporin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

7 January 2021

Renal dysfunction does not alter the pharmacokinetics or LDL-cholesterol reduction of atorvastatin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

7 January 2021

Cyclosporine A monitoring in patients with renal, cardiac, and liver transplants: a comparison between fluorescence polarization immunoassay and two different RIA methods.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

7 January 2021

Development, validation, and interlaboratory comparison of an HMG-CoA reductase inhibition assay for quantitation of atorvastatin in plasma matrices

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

7 January 2021

Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10415.X

7 January 2021

10.1034/J.1600-6143.2001.10415.X

Identifiers

DOI

1 reference

29 November 2017

1 reference